Bioethics News

Bone Marrow-Derived Stem Cells Offer Blood Transplant Patients Better Quality of Life

August 17, 2016

(Medical Xpress) – A large, nationwide study published in the journal JAMA Oncology found that people who received transplants of cells collected from a donor’s bone marrow the original source for blood stem cell transplants, developed decades ago had better self-reported psychological well-being, experienced fewer symptoms of a common post-transplant side effect called graft-vs.-host disease and were more likely to be back at work five years after transplantation than those whose transplanted cells were taken from the donor’s bloodstream.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.